These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 96891)

  • 1. Fibrinogen and ADP-induced platelet aggregation.
    Mustard JF; Packham MA; Kinlough-Rathbone RL; Perry DW; Regoeczi E
    Blood; 1978 Aug; 52(2):453-66. PubMed ID: 96891
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibitors of ADP-induced platelet aggregation prevent fibrinogen binding to rabbit platelets and cause rapid deaggregation and dissociation of bound fibrinogen.
    Harfenist EJ; Packham MA; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1981 May; 97(5):680-8. PubMed ID: 6783712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrin-induced release of platelet serotonin.
    Orloff KG; Michaeli D
    Am J Physiol; 1976 Aug; 231(2):344-50. PubMed ID: 961885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the interactions of fibrinogen and soluble fibrin with washed rabbit platelets stimulated with ADP.
    Harfenist EJ; Packham MA; Mustard JF
    Thromb Haemost; 1985 Apr; 53(2):183-7. PubMed ID: 3927504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identical behavior of fibrinogen and asialo-fibrinogen in reactions with platelets during ADP-induced aggregation.
    Harfenist EJ; Packham MA; Mustard JF
    Thromb Res; 1980 Nov; 20(3):353-8. PubMed ID: 7209886
    [No Abstract]   [Full Text] [Related]  

  • 6. Enzyme activities on the platelet surface in relation to the action of adenosine diphosphate.
    Mustard JF; Packham MA; Perry DW; Guccione MA; Kinlough-Rathbone RL
    Ciba Found Symp; 1975; 35():47-75. PubMed ID: 179770
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of oral contraceptives, or lanosterol, on ADP-induced aggregation and binding of 125I-fibrinogen to rat platelets.
    McGregor L; Toor B; McGregor JL; Renaud S; Clemetson KJ
    Thromb Res; 1984 Mar; 33(5):517-22. PubMed ID: 6719398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet prostaglandin production and its implications.
    Smith JB; Ingerman CM; Silver MJ
    Adv Prostaglandin Thromboxane Res; 1976; 2():747-53. PubMed ID: 983875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of prostaglandins and drotaverine on ADP-induced platelet aggregation.
    Losonczy H; Nagy I; Gregus Z
    Acta Med Acad Sci Hung; 1974; 31(3-4):157-63. PubMed ID: 4469713
    [No Abstract]   [Full Text] [Related]  

  • 10. Quantification of the morphological reaction of platelets to aggregating agents and of its reversal by aggregation inhibitors.
    Born GV; Dearnley R; Foulks JG; Sharp DE
    J Physiol; 1978 Jul; 280():193-212. PubMed ID: 99512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Affinity labeling of a human platelet membrane protein with 5'-p-fluorosulfonylbenzoyl adenosine. Concomitant inhibition of ADP-induced platelet aggregation and fibrinogen receptor exposure.
    Figures WR; Niewiarowski S; Morinelli TA; Colman RF; Colman RW
    J Biol Chem; 1981 Aug; 256(15):7789-95. PubMed ID: 6267026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influences of prostaglandins on electrophoretic mobility and aggregation of rabbit platelets.
    Takano S; Itagaki S; Sakurai K; Suzuki T
    Prostaglandins; 1980 Sep; 20(3):579-86. PubMed ID: 6999547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of plasmin on rabbit platelets.
    Guccione MA; Kinlough-Rathbone RL; Packham MA; Harfenist EJ; Rand ML; Greenberg JP; Perry DW; Mustard JF
    Thromb Haemost; 1985 Feb; 53(1):8-14. PubMed ID: 3158094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet aggregation and exposure of fibrinogen receptors by prostaglandin endoperoxide analogues.
    Morinelli TA; Niewiarowski S; Kornecki E; Figures WR; Wachtfogel Y; Colman RW
    Blood; 1983 Jan; 61(1):41-9. PubMed ID: 6293626
    [No Abstract]   [Full Text] [Related]  

  • 15. Interaction of nucleotide affinity analog 5'-p-fluorosulfonylbenzoyladenosine with platelet ADP receptor: aggregin.
    Figures WR; Scearce LM; Colman RF; Colman RW
    Methods Enzymol; 1992; 215():143-55. PubMed ID: 1435320
    [No Abstract]   [Full Text] [Related]  

  • 16. Action mechanism of the platelet aggregation inducer and inhibitor from Echis carinatus snake venom.
    Teng CM; Ma YH; Ouyang CH
    Biochim Biophys Acta; 1985 Jul; 841(1):8-14. PubMed ID: 3926005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin opposes prostanoid and non-prostanoid platelet inhibitors by direct enhancement of aggregation.
    MacIntyre DE; Handin RI; Rosenberg R; Salzman EW
    Thromb Res; 1981 Apr 1-15; 22(1-2):167-75. PubMed ID: 6270842
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of aggregation inducers and inhibitors on the functional properties and the ultrastructure of platelets].
    Lakin KM; Makarow WA; Mular AG
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):849-52. PubMed ID: 94877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversibility of the association of fibrinogen with rabbit platelets exposed to ADP.
    Harfenist EJ; Packham MA; Mustard JF
    Blood; 1980 Aug; 56(2):189-98. PubMed ID: 7397377
    [No Abstract]   [Full Text] [Related]  

  • 20. Human platelet clumping by bovine fibrinogen.
    Donati MB; De Gaetano G; Vermylen J
    Acta Univ Carol Med Monogr; 1972; 53():21-6. PubMed ID: 4275440
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.